Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

17β-Dihydroequilin

From Wikipedia, the free encyclopedia
Chemical compound
Not to be confused with17α-Dihydroequilin,17α-Dihydroequilenin, or17β-Dihydroequilenin.
Pharmaceutical compound
17β-Dihydroequilin
Clinical data
Other namesβ-Dihydroequilin; Δ7-17β-Estradiol; 7-Dehydro-17β-estradiol; Estra-1,3,5(10),7-tetraen-3,17β-diol; NSC-12170
Routes of
administration
By mouth
Drug classEstrogen
Identifiers
  • (9S,13S,14S,17S)-13-Methyl-6,9,11,12,14,15,16,17-octahydrocyclopenta[a]phenanthrene-3,17-diol
CAS Number
PubChemCID
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.020.576Edit this at Wikidata
Chemical and physical data
FormulaC18H22O2
Molar mass270.372 g·mol−1
3D model (JSmol)
  • C[C@]12CC[C@H]3C(=CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@H]2O
  • InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3-5,10,14,16-17,19-20H,2,6-9H2,1H3/t14-,16+,17+,18+/m1/s1
  • Key:NLLMJANWPUQQTA-UBDQQSCGSA-N

17β-Dihydroequilin is anaturally occurringestrogensex hormone found inhorses as well as amedication.[1][2] As the C3sulfateestersodiumsalt, it is a minor constituent (1.7%) ofconjugated estrogens (CEEs; brand namePremarin).[1] However, asequilin, withequilin sulfate being a major component of CEEs, is transformed into 17β-dihydroequilin in the body, analogously to the conversion ofestrone into estradiol, 17β-dihydroequilin is, along with estradiol, the most important estrogen responsible for the effects of CEEs.[1]

Pharmacology

[edit]

Pharmacodynamics

[edit]

17β-Dihydroequilin is an estrogen, or anagonist of theestrogen receptors (ERs), theERα andERβ.[1] In terms ofrelative binding affinity for the ERs, 17β-dihydroequilin has about 113% and 108% of that of estradiol for the ERα and ERβ, respectively.[1] 17β-Dihydroequilin has about 83% of the relative potency of CEEs in thevagina and 200% of the relative potency of CEEs in theuterus.[1] Of theequine estrogens, it shows the highestestrogenicactivity and greatest estrogenicpotency.[1]

Like CEEs as a whole, 17β-dihydroequilin has disproportionate effects in certaintissues such as theliver anduterus.[1]Equilin, the second major component of conjugated estrogens afterestrone, is reversiblytransformed into 17β-dihydroequilin analogously to the transformation of estrone into estradiol.[1] However, whereas the balance of mutual interconversion of estrone and estradiol is largely shifted in the direction of estrone, it is nearly equal in the case of equilin and 17β-dihydroequilin.[1] As such, although 17β-dihydroequilin is only a minor constituent of CEEs, it is, along with estradiol, the most important estrogen relevant to the estrogenic activity of the medication.[1]

Relative oral potencies of estrogens
EstrogenHFTooltip Hot flashesVETooltip Vaginal epitheliumUCaTooltip Urinary calciumFSHTooltip Follicle-stimulating hormoneLHTooltip Luteinizing hormoneHDLTooltip High-density lipoprotein-CTooltip CholesterolSHBGTooltip Sex hormone-binding globulinCBGTooltip Corticosteroid-binding globulinAGTTooltip AngiotensinogenLiver
Estradiol1.01.01.01.01.01.01.01.01.01.0
Estrone???0.30.3?????
Estriol0.30.30.10.30.30.2???0.67
Estrone sulfate?0.90.90.8–0.90.90.50.90.5–0.71.4–1.50.56–1.7
Conjugated estrogens1.21.52.01.1–1.31.01.53.0–3.21.3–1.55.01.3–4.5
Equilin sulfate??1.0??6.07.56.07.5?
Ethinylestradiol12015040060–150100400500–600500–6003502.9–5.0
Diethylstilbestrol???2.9–3.4??26–2825–37205.7–7.5
Sources and footnotes
Notes: Values are ratios, with estradiol as standard (i.e., 1.0).Abbreviations:HF = Clinical relief ofhot flashes.VE = Increasedproliferation ofvaginal epithelium.UCa = Decrease inUCaTooltip urinary calcium.FSH = Suppression ofFSHTooltip follicle-stimulating hormone levels.LH = Suppression ofLHTooltip luteinizing hormone levels.HDL-C,SHBG,CBG, andAGT = Increase in the serum levels of theseliver proteins. Liver = Ratio of liver estrogenic effects to general/systemic estrogenic effects (hot flashes/gonadotropins).Sources: See template.

Pharmacokinetics

[edit]

17β-Dihydroequilin has about 30% of therelative binding affinity oftestosterone forsex hormone-binding globulin (SHBG), relative to 50% forestradiol.[1] Themetabolic clearance rate of 17β-dihydroequilin is 1,250 L/day/m2, relative to 580 L/day/m2 for estradiol.[1]

Chemistry

[edit]
See also:List of estrogens § Equine estrogens

17β-Dihydroequilin, or simply β-dihydroequilin, also known as δ7-17β-estradiol or as 7-dehydro-17β-estradiol, as well as estra-1,3,5(10),7-tetraen-3,17β-diol, is anaturally occurringestranesteroid and ananalogue ofestradiol.[1] In terms ofchemical structure andpharmacology, equilin (δ7-estrone) is to 17β-dihydroequilin asestrone is to estradiol.[1]

References

[edit]
  1. ^abcdefghijklmnoKuhl H (2005)."Pharmacology of estrogens and progestogens: influence of different routes of administration"(PDF).Climacteric.8 (Suppl 1):3–63.doi:10.1080/13697130500148875.PMID 16112947.S2CID 24616324.
  2. ^Fritz MA, Speroff L (28 March 2012)."Postmenopausal Hormone Therapy".Clinical Gynecologic Endocrinology and Infertility. Lippincott Williams & Wilkins. pp. 751–.ISBN 978-1-4511-4847-3.


Estrogens
ERTooltip Estrogen receptor agonists
Progonadotropins
Antiestrogens
ERTooltip Estrogen receptor antagonists
(incl.SERMsTooltip selective estrogen receptor modulators/SERDsTooltip selective estrogen receptor downregulators)
Aromatase inhibitors
Antigonadotropins
Others
ERTooltip Estrogen receptor
Agonists
Mixed
(SERMsTooltip Selective estrogen receptor modulators)
Antagonists
GPERTooltip G protein-coupled estrogen receptor
Agonists
Antagonists
Unknown
Retrieved from "https://en.wikipedia.org/w/index.php?title=17β-Dihydroequilin&oldid=1191745331"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp